| Structure |
Chemical Name |
CAS |
MF |
 |
R-afatinib |
945553-91-3 |
C24H25ClFN5O3 |
 |
dextroMethorphanone |
|
|
![2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine](/CAS/20150408/GIF/97151-10-5.gif) |
2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine |
97151-10-5 |
C24H25NO |
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180703/GIF/1598416-08-0.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-08-0 |
C22H18Cl2N2O5 |
 |
For the determination of
impurities in Propylene |
|
|
 |
Saxagliptin Impurity 7 |
|
|
 |
E-Ceftazidime Oxide Impurity |
|
|
 |
2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
246512-44-7 |
C15H23N3O4 |
 |
オルト-メトプロロール |
163685-38-9 |
C15H25NO3 |
![5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one](/CAS/GIF/139756-31-3.gif) |
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
139756-31-3 |
C16H17ClN4O4S |
 |
Butyphthalide impurity 29 |
|
|
 |
5-chloro-3-sulfo-2-Thiophenecarboxylic acid |
187746-94-7 |
C5H3ClO5S2 |
![Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride)](/CAS/GIF/67775-97-7.gif) |
Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) |
67775-97-7 |
C17H27ClN2O2 |
 |
Rivaroxaban Impurity 65 |
|
|
 |
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
 |
Nitrendipine iMpurity G |
|
|
 |
Imatinib Impurity 3 |
|
|
 |
(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
1428118-12-0 |
C37H43FN2O5 |
 |
(O-Isobutyryl (R)-Fesoterodine |
1795786-25-2 |
C30H43NO4 |
 |
Cefuroxime Impurity 9 |
2165460-37-5 |
C8H10N2O4S |
 |
Linagliptin Impurity 26 |
2446799-71-7 |
C20H17BrN6O2 |
 |
Tazobactam Impurity 10 |
|
|
 |
2-(2-メチル-4-ニトロ-1-イミダゾリル)エタノール |
705-19-1 |
C6H9N3O3 |
 |
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
 |
Brexpiprazole Impurity |
2116542-21-1 |
C38H40N4O4S |
 |
BIRG 613 BS |
287980-85-2 |
C15H16N4O |
 |
12-O-メチルクラリスロマイシン |
128940-83-0 |
C39H71NO13 |
 |
Dinitrogen oxide-15N |
20509-24-4 |
N15NO |
 |
Empagliflozin Impurity 17 |
2452301-27-6 |
C23H28O7 |
 |
Rivaroxaban Degradation Impurity C |
|
|
 |
1-NaphthaleneacetaMide, 1,2,3,4-tetrahydro-7-Methoxy- |
92041-01-5 |
C13H17NO2 |
 |
5-hydroxy-N,1,2-trimethyl-1H-indole-3-carboxamide |
|
|
 |
Palbociclib Impurity 32 |
|
|
 |
Loratadine Impurity 1 |
|
C22H23ClN2O2 |
 |
RocuroniuM BroMide IMpurity 19 |
|
|
 |
Palbociclib Impurity 31 |
2955712-44-2 |
|
 |
2-Demethoxy-4-methoxy urapidil |
34661-79-5 |
C20H29N5O3 |
 |
アミホスチンチオール二塩酸塩 (90%) |
14653-77-1 |
C5H14N2S |
 |
Posaconazole iMpurity 7 |
2180759-84-4 |
C37H42F2N8O4 |
 |
DONEPEZIL HYDROCHLORIDE |
110119-84-1 |
C24H30ClNO3 |
 |
(4-メチルキナゾリン-2-イル)メタノール |
13535-91-6 |
C10H10N2O |
![(1R,2S,5S)-2-アジド-5-[(ジメチルアミノ)カルボニル]シクロヘキシルカルバミン酸=tert-ブチル](/CAS/20180906/GIF/480450-69-9.gif) |
(1R,2S,5S)-2-アジド-5-[(ジメチルアミノ)カルボニル]シクロヘキシルカルバミン酸=tert-ブチル |
480450-69-9 |
C14H25N5O3 |
![bis(6-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzo[d][1,3]dioxol-5-yl)methane](/CAS/20200331/GIF/2105932-71-4.gif) |
bis(6-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzo[d][1,3]dioxol-5-yl)methane |
2105932-71-4 |
C39H40F2N2O6 |
 |
3-Dechloro Sertraline Hydrochloride |
79646-00-7 |
C17H18ClN.ClH |
 |
Moxidectin |
119718-45-5 |
C37H53NO8 |
 |
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol |
1358581-37-9 |
C25H27FO6S |
 |
Dexamethasone EP impurities E |
|
|
 |
Formoterol Impurity 13 |
150513-24-9 |
C18H24N2O3 |
 |
Cefminox Sodium impurity E |
|
|
 |
6β-Methylprednisolone |
18462-27-6 |
C22H30O5 |
 |
Paris polyphylla |
|
|
 |
Isomer 1 of Tazobactam Impurity 3 |
|
|
 |
Cefadroxil Impurity 6 |
2378158-45-1 |
C32H32N6O9S2 |
 |
Afatinib impurity 28 |
|
|
 |
Irbesartan IMpurity E |
|
C25H28N6O |
 |
Ketoconazole Impurity 7 |
172032-21-2 |
C11H12Cl2O3 |
 |
Cefaclor Impurity 5 |
|
|
 |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
 |
(1-ジアゾ-2-オキソプロピル)ホスホン酸ジメチル |
90965-06-3 |
C5H9N2O4P |
 |
LUMAT-004 |
313544-31-9 |
C16H17N3O3 |
 |
Celecoxib Impurity 19 |
|
C17H14F3N3O2S |
 |
Pyrazole |
|
|
 |
Aprepitant Impurity 23 |
|
|
 |
N,N'-Bis(4-hydroxyphenyl)hydrazine |
158905-63-6 |
C12H12N2O2 |
 |
Peramivir Deacetyl Impurity |
|
|
 |
(2-メチル-4-ニトロ-1H-イミダゾール-1-イル)酢酸 |
16230-87-8 |
C6H7N3O4 |
 |
Erlotinib Impurity 19 |
|
|
 |
3-(1-アジリジニル)プロピルアミン |
1072-65-7 |
C5H12N2 |
![L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester](/CAS/20210111/GIF/1119226-56-0.gif) |
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester |
1119226-56-0 |
C30H55NO5 |
 |
Desloratadine Impurity |
50603-12-8 |
C20H21N |
 |
Cabozantinib impurity 31 |
|
|
 |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
 |
Febuxostat Impurity 94 |
|
|
 |
EthanediaMide iMpurity D |
480452-36-6 |
C21H30ClN5O5 |
 |
Nicergoline EP Impurity G |
57935-65-6 |
C23H24BrN3O2 |
 |
Vildagliptin Impurity 9 |
|
|
 |
tirofiban |
464175-13-1 |
C9H18ClN |
 |
(S)-Olodaterol |
868049-50-7 |
C21H26N2O5 |
 |
Esomeprazole Impurity 26 |
704910-88-3 |
C15H15N3OS |
![(S)-10-(1-aminocyclopropyl)-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid formic acid](/CAS/20200401/GIF/CB65441219.gif) |
(S)-10-(1-aminocyclopropyl)-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid formic acid |
|
C17H18N2O6 |
 |
sofosBuvir impurity 36 |
|
|
 |
Valsartan Impurity 13 |
|
C24H29N5O3 |
![6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one](/CAS/20200119/GIF/1361569-10-9.gif) |
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one |
1361569-10-9 |
C18H13FN8O |
![ジメチル[(3S)-3-(1-ナフチルオキシ)-3-(2-チエニル)プロピル]アミン](/CAS/GIF/132335-46-7.gif) |
ジメチル[(3S)-3-(1-ナフチルオキシ)-3-(2-チエニル)プロピル]アミン |
132335-46-7 |
C19H21NOS |
 |
クロロ-N-(2,4-ジメチルフェニル)アセトアミド |
39106-10-0 |
C10H12ClNO |
 |
Fludarabine EP impurity J |
|
|
 |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
 |
Febuxostat Impurity 79 |
|
|
 |
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
![(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB92667983.gif) |
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
1644461-85-7 |
C23H28F2N6O5S |
 |
Tofacitinib Impurity K |
2328165-36-0 |
C16H21N5O3 |
 |
Minocycline N-Hydroxymethyl Impurity |
1075240-33-3 |
C24H29N3O8 |
 |
Milrinone Impurity 7 |
2250242-59-0 |
C14H13N3O |
 |
IRAS vials are low alkaline and meet the pharmacopoeia standards of various countries |
|
|
 |
Rupatadine Impurity 7 |
1704730-21-1 |
C26H26ClN3O |
 |
Plerixafor Impurity 1 |
|
|
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate](/CAS/20180703/GIF/1038924-97-8.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
 |
Febuxostat Impurity 56 |
|
|
 |
炭酸クロロメチルエチル |
35179-98-7 |
C4H7ClO3 |
 |
Linagliptin Impurity 40 |
|
|